RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($) |
3 Months Ended | ||
|---|---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
Jul. 28, 2016 |
|
| Louis and Carolyn Lucido CRT LLC [Member] | |||
| Subscription and royalty agreement description | Pursuant to the Subscription and Royalty Agreements: (i) Each party would purchase shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), in the aggregate amount of $3,000,000 at a purchase price of $15.00 per share (the “Purchase Price”), for a total of 200,000 shares of Common Stock; and (ii) the Company shall pay each (a) a total of $37.50 from the gross revenue derived from each of its weight loss treatments sold in the United States starting on the first (1st) day that the first unit of the treatment is sold (the “Initial Sales Date”) and ending on the third (3rd) anniversary of the Initial Sales Date; and (b) a total of $25.00 from the gross revenue derived from each of its weight loss treatments sold in the United States starting on the day following the third (3rd) anniversary of the Initial Sales Date and ending on the fifteenth (15th) anniversary of the Initial Sales Date (the “Royalty”). | ||
| BioCorRx Pharmaceuticals, Inc [Member] | |||
| Ownership percentage hold by former officers | 24.20% | ||
| Ownership percentage hold by company | 75.80% | ||
| Mr. Tom Welch, VP of Operations [Member] | |||
| Monthly remuneration | $ 12,500 | ||
| Consulting fees | 37,500 | $ 35,000 | |
| Unpaid balance | 0 | 0 | |
| Soupface LLC [Member] | |||
| Monthly remuneration | 14,583 | ||
| Consulting fees | 47,500 | 43,750 | |
| Unpaid balance | $ 0 | $ 0 | |